{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:58:44Z","timestamp":1790740724451,"version":"4.1.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82572622, 82272382, 82150610507, 82072320"],"award-info":[{"award-number":["82572622, 82272382, 82150610507, 82072320"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LZ24H190001"],"award-info":[{"award-number":["LZ24H190001"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infection"],"DOI":"10.1007\/s15010-026-02889-6","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T10:19:39Z","timestamp":1783678779000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Rapid expansion of penA allele 60.001-containing endemic ceftriaxone-resistant gonococcal ST8123 lineage in Hangzhou, China"],"prefix":"10.1007","author":[{"given":"Xia","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu\u2019ai","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8176-391X","authenticated-orcid":false,"given":"Stijn","family":"van der Veen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,10]]},"reference":[{"key":"2889_CR1","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1071\/SH19023","volume":"16","author":"M Unemo","year":"2019","unstructured":"Unemo M, Lahra MM, Cole M, Galarza P, Ndowa F, Martin I, et al. World Health Organization Global Gonococcal Antimicrobial Surveillance Program (WHO GASP): review of new data and evidence to inform international collaborative actions and research efforts. Sex Health. 2019;16:412\u201325.","journal-title":"Sex Health"},{"key":"2889_CR2","doi-asserted-by":"publisher","first-page":"4339","DOI":"10.1128\/AAC.00504-16","volume":"60","author":"S Nakayama","year":"2016","unstructured":"Nakayama S, Shimuta K, Furubayashi K, Kawahata T, Unemo M, Ohnishi M. New ceftriaxone- and multidrug-resistant Neisseria gonorrhoeae strain with a novel mosaic penA gene isolated in Japan. Antimicrob Agents Chemother. 2016;60:4339\u201341.","journal-title":"Antimicrob Agents Chemother"},{"key":"2889_CR3","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1097\/IM9.0000000000000113","volume":"5","author":"S van der Veen","year":"2023","unstructured":"van der Veen S. Global transmission of the penA allele 60.001-containing high-level ceftriaxone-resistant gonococcal FC428 clone and antimicrobial therapy of associated cases: A review. Infect Microb Dis. 2023;5:13\u201320.","journal-title":"Infect Microb Dis"},{"key":"2889_CR4","doi-asserted-by":"publisher","first-page":"735","DOI":"10.3201\/eid2404.171873","volume":"24","author":"MM Lahra","year":"2018","unstructured":"Lahra MM, Martin I, Demczuk W, Jennison AV, Lee KI, Nakayama SI, et al. Cooperative recognition of internationally disseminated ceftriaxone-resistant Neisseria gonorrhoeae strain. Emerg Infect Dis. 2018;24:735\u201340.","journal-title":"Emerg Infect Dis"},{"key":"2889_CR5","first-page":"101125","volume":"48","author":"PT Lan","year":"2024","unstructured":"Lan PT, Nguyen HT, Golparian D, Thuy Van NT, Maatouk I, Unemo M. The WHO Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP) identifies high levels of ceftriaxone resistance across Vietnam, 2023. Lancet Reg Health West Pac. 2024;48:101125.","journal-title":"Lancet Reg Health West Pac"},{"key":"2889_CR6","doi-asserted-by":"publisher","first-page":"e332","DOI":"10.1016\/S1473-3099(23)00479-6","volume":"23","author":"V Ouk","year":"2023","unstructured":"Ouk V, Pham CD, Wi T, van Hal SJ, Lahra MM. The enhanced gonococcal surveillance programme, Cambodia. Lancet Infect Dis. 2023;23:e332\u20133.","journal-title":"Lancet Infect Dis"},{"key":"2889_CR7","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1093\/jac\/dkaa526","volume":"76","author":"J Yan","year":"2021","unstructured":"Yan J, Chen Y, Yang F, Ling X, Jiang S, Zhao F, et al. High percentage of the ceftriaxone-resistant Neisseria gonorrhoeae FC428 clone among isolates from a single hospital in Hangzhou, China. J Antimicrob Chemother. 2021;76:936\u20139.","journal-title":"J Antimicrob Chemother"},{"key":"2889_CR8","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1080\/22221751.2020.1773325","volume":"9","author":"K Zhou","year":"2020","unstructured":"Zhou K, Chen SC, Yang F, van der Veen S, Yin YP. Impact of the gonococcal FC428 penA allele 60.001 on ceftriaxone resistance and biological fitness. Emerg Microbes Infect. 2020;9:1219\u201329.","journal-title":"Emerg Microbes Infect"},{"key":"2889_CR9","doi-asserted-by":"publisher","first-page":"e02311","DOI":"10.1128\/AAC.02311-20","volume":"65","author":"Y Li","year":"2021","unstructured":"Li Y, Li Y, Xiu L, Zeng Y, Zhang C, Sun L, et al. Typing of Neisseria gonorrhoeae isolates in Shenzhen, China from 2014\u20132018 reveals the shift of genotypes associated with antimicrobial resistance. Antimicrob Agents Chemother. 2021;65:e02311\u201320.","journal-title":"Antimicrob Agents Chemother"},{"key":"2889_CR10","doi-asserted-by":"publisher","first-page":"2854","DOI":"10.1093\/jac\/dkae297","volume":"79","author":"F Yang","year":"2024","unstructured":"Yang F, Sun X, Fu Y, Zhao F, Lin X, Chen Y, et al. High-level ceftriaxone resistance due to transfer of penA allele 60.001 into endemic gonococcal lineages in Hangzhou, China. J Antimicrob Chemother. 2024;79:2854\u20137.","journal-title":"J Antimicrob Chemother"},{"key":"2889_CR11","doi-asserted-by":"publisher","first-page":"2579397","DOI":"10.1080\/22221751.2025.2579397","volume":"14","author":"C Zhang","year":"2025","unstructured":"Zhang C, Yang Y, Zhu B, Tang X, Zhong N, Wang Y, et al. Emergence, evolution and temporal spread of ceftriaxone-resistant Neisseria gonorrhoeae in China from 2002 to 2022: a retrospective genomic surveillance study. Emerg Microbes Infect. 2025;14:2579397.","journal-title":"Emerg Microbes Infect"},{"key":"2889_CR12","doi-asserted-by":"crossref","unstructured":"van der Veen S, Sun X, Ge H, Chau TM, Nhung PH, Vandelannoote K et al. PenA alleles associated with gonococcal ceftriaxone resistance in Cambodia, China and Vietnam. Clin Infect Dis. 2025.","DOI":"10.1093\/cid\/ciaf530"},{"key":"2889_CR13","doi-asserted-by":"publisher","first-page":"pii","DOI":"10.2807\/1560-7917.ES.2022.27.46.2200803","volume":"27","author":"M Day","year":"2022","unstructured":"Day M, Pitt R, Mody N, Saunders J, Rai R, Nori A, et al. Detection of 10 cases of ceftriaxone-resistant Neisseria gonorrhoeae in the United Kingdom, December 2021 to June 2022. Euro Surveill. 2022;27:pii\u2013.","journal-title":"Euro Surveill"},{"key":"2889_CR14","doi-asserted-by":"publisher","first-page":"pii","DOI":"10.2807\/1560-7917.ES.2022.27.50.2200899","volume":"27","author":"B Ber\u00e7ot","year":"2022","unstructured":"Ber\u00e7ot B, Cam\u00e9l\u00e9na F, M\u00e9rim\u00e8che M, Jacobsson S, Sbaa G, Mainardis M, et al. Ceftriaxone-resistant, multidrug-resistant Neisseria gonorrhoeae with a novel mosaic penA-237.001 gene, France. Euro Surveill. 2022;27:pii\u2013.","journal-title":"Euro Surveill"},{"key":"2889_CR15","doi-asserted-by":"publisher","first-page":"pii","DOI":"10.2807\/1560-7917.ES.2023.28.10.2300125","volume":"28","author":"D Golparian","year":"2023","unstructured":"Golparian D, Vestberg N, S\u00f6dersten W, Jacobsson S, Ohnishi M, Fang H, et al. Multidrug-resistant Neisseria gonorrhoeae isolate SE690: mosaic penA-60.001 gene causing ceftriaxone resistance internationally has spread to the more antimicrobial-susceptible genomic lineage, Sweden, September 2022. Euro Surveill. 2023;28:pii\u2013.","journal-title":"Euro Surveill"},{"key":"2889_CR16","doi-asserted-by":"publisher","first-page":"pii","DOI":"10.2807\/1560-7917.ES.2022.27.24.2200455","volume":"27","author":"S Pleininger","year":"2022","unstructured":"Pleininger S, Indra A, Golparian D, Heger F, Schindler S, Jacobsson S, et al. Extensively drug-resistant (XDR) Neisseria gonorrhoeae causing possible gonorrhoea treatment failure with ceftriaxone plus azithromycin in Austria, April 2022. Euro Surveill. 2022;27:pii\u2013.","journal-title":"Euro Surveill"},{"key":"2889_CR17","doi-asserted-by":"publisher","first-page":"e149","DOI":"10.1016\/S1473-3099(23)00785-5","volume":"24","author":"JL Reimche","year":"2024","unstructured":"Reimche JL, Pham CD, Joseph SJ, Hutton S, Cartee JC, Ruan Y, et al. Novel strain of multidrug non-susceptible Neisseria gonorrhoeae in the USA. Lancet Infect Dis. 2024;24:e149\u201351.","journal-title":"Lancet Infect Dis"},{"key":"2889_CR18","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.15585\/mmwr.mm6949a5","volume":"69","author":"MA Picker","year":"2020","unstructured":"Picker MA, Knoblock RJ, Hansen H, Bautista I, Griego R, Barber L, et al. Notes from the field: First case in the United States of Neisseria gonorrhoeae harboring emerging mosaic penA60 allele, conferring reduced susceptibility to cefixime and ceftriaxone. MMWR Morb Mortal Wkly Rep. 2020;69:1876\u20137.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2889_CR19","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.3201\/eid2507.190172","volume":"25","author":"SC Chen","year":"2019","unstructured":"Chen SC, Han Y, Yuan LF, Zhu XY, Yin YP. Identification of internationally disseminated ceftriaxone-resistant Neisseria gonorrhoeae strain FC428, China. Emerg Infect Dis. 2019;25:1427\u20139.","journal-title":"Emerg Infect Dis"},{"key":"2889_CR20","doi-asserted-by":"publisher","first-page":"3635","DOI":"10.1093\/jac\/dkz384","volume":"74","author":"F Yang","year":"2019","unstructured":"Yang F, Zhang H, Chen Y, Zhai Y, Zhao F, Yu Y, et al. Detection and analysis of two cases of the internationally spreading ceftriaxone-resistant Neisseria gonorrhoeae FC428 clone in China. J Antimicrob Chemother. 2019;74:3635\u20136.","journal-title":"J Antimicrob Chemother"},{"key":"2889_CR21","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.3201\/eid3008.240139","volume":"30","author":"L Xiu","year":"2024","unstructured":"Xiu L, Zhang L, Peng J. Surge in ceftriaxone-resistant Neisseria gonorrhoeae FC428-like strains, Asia-Pacific region, 2015\u20132022. Emerg Infect Dis. 2024;30:1683\u20136.","journal-title":"Emerg Infect Dis"},{"key":"2889_CR22","doi-asserted-by":"crossref","unstructured":"Unitt A, Krisna M, Parfitt KM, Jolley KA, Maiden MCJ, Harrison OB. Neisseria gonorrhoeae LIN codes: a robust, multi-resolution lineage nomenclature. bioRxiv. 2025.03.28.646058.","DOI":"10.7554\/eLife.107758.2"},{"key":"2889_CR23","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1099\/13500872-141-3-611","volume":"141","author":"KE Hagman","year":"1995","unstructured":"Hagman KE, Pan W, Spratt BG, Balthazar JT, Judd RC, Shafer WM. Resistance of Neisseria gonorrhoeae to antimicrobial hydrophobic agents is modulated by the mtrRCDE efflux system. Microbiology. 1995;141:611\u201322.","journal-title":"Microbiology"},{"key":"2889_CR24","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.eclinm.2019.01.010","volume":"7","author":"JP Peng","year":"2019","unstructured":"Peng JP, Yin YP, Chen SC, Yang J, Dai XQ, Zheng HP, et al. A whole-genome sequencing analysis of Neisseria gonorrhoeae isolates in China: an observational study. EClinicalMedicine. 2019;7:47\u201354.","journal-title":"EClinicalMedicine"},{"key":"2889_CR25","doi-asserted-by":"publisher","first-page":"e0172823","DOI":"10.1128\/spectrum.01728-23","volume":"11","author":"D Wang","year":"2023","unstructured":"Wang D, Li Y, Zhang C, Zeng Y, Peng J, Wang F. Genomic epidemiology of Neisseria gonorrhoeae in Shenzhen, China, during 2019\u20132020: increased spread of ceftriaxone-resistant isolates brings insights for strengthening public health responses. Microbiol Spectr. 2023;11:e0172823.","journal-title":"Microbiol Spectr"},{"key":"2889_CR26","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1093\/jac\/dkaa123","volume":"75","author":"H Wang","year":"2020","unstructured":"Wang H, Wang Y, Yong G, Li X, Yu L, Ma S, et al. Emergence and genomic characterization of the ceftriaxone-resistant Neisseria gonorrhoeae FC428 clone in Chengdu, China. J Antimicrob Chemother. 2020;75:2495\u20138.","journal-title":"J Antimicrob Chemother"},{"key":"2889_CR27","doi-asserted-by":"publisher","first-page":"e351","DOI":"10.1016\/S1473-3099(24)00230-5","volume":"24","author":"PC Adamson","year":"2024","unstructured":"Adamson PC, Hieu VN, Nhung PH, Whiley DM, Chau TM. Ceftriaxone resistance in Neisseria gonorrhoeae associated with the penA-60.001 allele in Hanoi, Viet Nam. Lancet Infect Dis. 2024;24:e351\u20132.","journal-title":"Lancet Infect Dis"},{"key":"2889_CR28","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s12941-023-00614-x","volume":"22","author":"D Wang","year":"2023","unstructured":"Wang D, Wang Y, Li Y, Xiu L, Yong G, Yang Y, et al. Identification of ceftriaxone-resistant Neisseria gonorrhoeae FC428 clone and isolates harboring a novel mosaic penA gene in Chengdu in 2019\u20132020. Ann Clin Microbiol Antimicrob. 2023;22:73.","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"2889_CR29","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.3201\/eid3007.240354","volume":"30","author":"V Ouk","year":"2024","unstructured":"Ouk V, Say HL, Virak M, Deng S, Frankson R, McDonald R, et al. World Health Organization Enhanced Gonococcal Antimicrobial Surveillance Programme, Cambodia, 2023. Emerg Infect Dis. 2024;30:1493\u20135.","journal-title":"Emerg Infect Dis"},{"key":"2889_CR30","doi-asserted-by":"publisher","first-page":"2300456","DOI":"10.2807\/1560-7917.ES.2023.28.37.2300456","volume":"28","author":"C Maubaret","year":"2023","unstructured":"Maubaret C, Cam\u00e9l\u00e9na F, Mrim\u00e8che M, Braille A, Liberge M, Mainardis M, et al. Two cases of extensively drug-resistant (XDR) Neisseria gonorrhoeae infection combining ceftriaxone-resistance and high-level azithromycin resistance, France, November 2022 and May 2023. Euro Surveill. 2023;28:2300456.","journal-title":"Euro Surveill"},{"key":"2889_CR31","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.3201\/eid3009.240557","volume":"30","author":"F Cam\u00e9l\u00e9na","year":"2024","unstructured":"Cam\u00e9l\u00e9na F, M\u00e9rim\u00e8che M, Brousseau J, Mainardis M, Verger P, Le Risb\u00e9 C, et al. Emergence of extensively drug-resistant Neisseria gonorrhoeae, France, 2023. Emerg Infect Dis. 2024;30:1903\u20136.","journal-title":"Emerg Infect Dis"},{"key":"2889_CR32","doi-asserted-by":"publisher","first-page":"3332","DOI":"10.1093\/jac\/dkae369","volume":"79","author":"H Fifer","year":"2024","unstructured":"Fifer H, Doumith M, Rubinstein L, Mitchell L, Wallis M, Singh S, et al. Ceftriaxone-resistant Neisseria gonorrhoeae detected in England, 2015-24: an observational analysis. J Antimicrob Chemother. 2024;79:3332\u20139.","journal-title":"J Antimicrob Chemother"},{"key":"2889_CR33","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1136\/sextrans-2024-056405","volume":"101","author":"MP McHugh","year":"2025","unstructured":"McHugh MP, Aburajab K, Maxwell A, Anderson J, Cairns F, Cotton S, et al. Investigation of ceftriaxone-resistant Neisseria gonorrhoeae detected in Scotland, 2018\u20132024. Sex Transm Infect. 2025;101:534\u20137.","journal-title":"Sex Transm Infect"},{"key":"2889_CR34","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1177\/09564624261435841","volume":"37","author":"R Cetatean","year":"2026","unstructured":"Cetatean R, Secci B, Lazzarotto T, Foschi C, Ambretti S. Detection and genomic characterization of an extensively drug-resistant Neisseria gonorrhoeae ST16406 isolate identified in Italy, 2025. Int J STD AIDS. 2026;37:788\u201393.","journal-title":"Int J STD AIDS"},{"key":"2889_CR35","first-page":"101709","volume":"63","author":"PT Lan","year":"2025","unstructured":"Lan PT, Phan Nguyen TT, Anh VT, Golparian D, Thuy Van NT, Maatouk I, et al. The World Health Organization (WHO) Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP) reports continuously high levels of ceftriaxone resistance across Viet Nam, 2024. Lancet Reg Health West Pac. 2025;63:101709.","journal-title":"Lancet Reg Health West Pac"},{"key":"2889_CR36","doi-asserted-by":"publisher","first-page":"e02069","DOI":"10.1128\/AAC.02069-17","volume":"62","author":"G Igawa","year":"2018","unstructured":"Igawa G, Yamagishi Y, Lee KI, Dorin M, Shimuta K, Suematsu H, et al. Neisseria cinerea with high ceftriaxone MIC is a source of ceftriaxone and cefixime resistance-mediating penA sequences in Neisseria gonorrhoeae. Antimicrob Agents Chemother. 2018;62:e02069\u201317.","journal-title":"Antimicrob Agents Chemother"},{"key":"2889_CR37","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1093\/jac\/dkab390","volume":"77","author":"I Kanesaka","year":"2022","unstructured":"Kanesaka I, Ohno A, Katsuse AK, Takahashi H, Kobayashi I. The emergence of the ceftriaxone-resistant Neisseria gonorrhoeae FC428 clone by transfer of resistance from an oral Neisseria subflava reservoir of resistance. J Antimicrob Chemother. 2022;77:364\u201373.","journal-title":"J Antimicrob Chemother"},{"key":"2889_CR38","first-page":"001209","volume":"10","author":"A Unitt","year":"2024","unstructured":"Unitt A, Maiden M, Harrison O. Characterizing the diversity and commensal origins of penA mosaicism in the genus Neisseria. Microb Genom. 2024;10:001209.","journal-title":"Microb Genom"},{"key":"2889_CR39","doi-asserted-by":"publisher","first-page":"4039","DOI":"10.1128\/AAC.00505-12","volume":"56","author":"T Deguchi","year":"2012","unstructured":"Deguchi T, Yasuda M, Ito S. Management of pharyngeal gonorrhea is crucial to prevent the emergence and spread of antibiotic-resistant Neisseria gonorrhoeae. Antimicrob Agents Chemother. 2012;56:4039\u201340.","journal-title":"Antimicrob Agents Chemother"},{"key":"2889_CR40","doi-asserted-by":"publisher","first-page":"e1002499","DOI":"10.1371\/journal.pmed.1002499","volume":"15","author":"YP Yin","year":"2018","unstructured":"Yin YP, Han Y, Dai XQ, Zheng HP, Chen SC, Zhu BY, et al. Susceptibility of Neisseria gonorrhoeae to azithromycin and ceftriaxone in China: A retrospective study of national surveillance data from 2013 to 2016. PLoS Med. 2018;15:e1002499.","journal-title":"PLoS Med"},{"key":"2889_CR41","first-page":"29","volume":"74","author":"J Yan","year":"2019","unstructured":"Yan J, Xue J, Chen Y, Chen S, Wang Q, Zhang C, et al. Increasing prevalence of Neisseria gonorrhoeae with decreased susceptibility to ceftriaxone and resistance to azithromycin in Hangzhou, China (2015-17). J Antimicrob Chemother. 2019;74:29\u201337.","journal-title":"J Antimicrob Chemother"}],"container-title":["Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-026-02889-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s15010-026-02889-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-026-02889-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T10:19:40Z","timestamp":1783678780000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s15010-026-02889-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,10]]},"references-count":41,"alternative-id":["2889"],"URL":"https:\/\/doi.org\/10.1007\/s15010-026-02889-6","relation":{},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"value":"0300-8126","type":"print"},{"value":"1439-0973","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,10]]},"assertion":[{"value":"30 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The Sir Run Run Shaw Hospital Ethics Committee approved the study [approval number 20190617-2] and the study is in accordance with the principles of the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}